Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
Evaluation of unfavourable outcome-related factors in patients affected by renal cell cancer in treatment with everolimus and previously treated with a Vascular endothelial growth factor (VEGF) inhibitor (i.e. sunitinib, sorafenib,pazopanib, or bevacizumab+interferon)
Epistemonikos ID: 5661e7db5f23d528404baf303d72eead77ab763f
First added on: May 12, 2024